Stockreport

Gilead's Vemlidy OK'd in Europe [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF As expected, the European Commission approves Gilead Sciences' (NASDAQ: GILD ) Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet for the treatment [Read more]